174 related articles for article (PubMed ID: 9106525)
1. Unusual patterns of exon skipping in Bruton tyrosine kinase are associated with mutations involving the intron 17 3' splice site.
Haire RN; Ohta Y; Strong SJ; Litman RT; Liu Y; Prchal JT; Cooper MD; Litman GW
Am J Hum Genet; 1997 Apr; 60(4):798-807. PubMed ID: 9106525
[TBL] [Abstract][Full Text] [Related]
2. An exon-skipping mutation in the btk gene of a patient with X-linked agammaglobulinemia and isolated growth hormone deficiency.
Duriez B; Duquesnoy P; Dastot F; Bougnères P; Amselem S; Goossens M
FEBS Lett; 1994 Jun; 346(2-3):165-70. PubMed ID: 8013627
[TBL] [Abstract][Full Text] [Related]
3. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
Saha BK; Curtis SK; Vogler LB; Vihinen M
Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
[TBL] [Abstract][Full Text] [Related]
4. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
Hagemann TL; Chen Y; Rosen FS; Kwan SP
Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
[TBL] [Abstract][Full Text] [Related]
5. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
6. Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.
Ohta Y; Haire RN; Litman RT; Fu SM; Nelson RP; Kratz J; Kornfeld SJ; de la Morena M; Good RA; Litman GW
Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9062-6. PubMed ID: 8090769
[TBL] [Abstract][Full Text] [Related]
7. DNA-based mutation analysis of Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinaemia.
Vorechovský I; Vihinen M; de Saint Basile G; Honsová S; Hammarström L; Müller S; Nilsson L; Fischer A; Smith CI
Hum Mol Genet; 1995 Jan; 4(1):51-8. PubMed ID: 7711734
[TBL] [Abstract][Full Text] [Related]
8. Four novel and three recurrent mutations of the BTK gene and pathogenic effects of putative splice mutations.
Wattanasirichaigoon D; Benjaponpitak S; Techasaensiri C; Kamchaisatian W; Vichyanond P; Janwityanujit S; Choubtum L; Sirinavin S
J Hum Genet; 2006; 51(11):1006-1014. PubMed ID: 16951917
[TBL] [Abstract][Full Text] [Related]
9. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.
Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J
Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697
[TBL] [Abstract][Full Text] [Related]
10. Expression of Bruton's tyrosine kinase in B lymphoblastoid cell lines from X-linked agammaglobulinaemia patients.
De Weers M; Dingjan GM; Brouns GS; Kraakman ME; Mensink RG; Lovering RC; Schuurman RK; Borst J; Hendriks RW
Clin Exp Immunol; 1997 Feb; 107(2):235-40. PubMed ID: 9030858
[TBL] [Abstract][Full Text] [Related]
11. Identification of mutations in the Bruton's tyrosine kinase gene, including a novel genomic rearrangements resulting in large deletion, in Korean X-linked agammaglobulinemia patients.
Jo EK; Wang Y; Kanegane H; Futatani T; Song CH; Park JK; Kim JS; Kim DS; Ahn KM; Lee SI; Park HJ; Hahn YS; Lee JH; Miyawaki T
J Hum Genet; 2003; 48(6):322-326. PubMed ID: 12768435
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase.
Mesci L; Ozdag H; Turul T; Ersoy F; Tezcan I; Sanal O
Turk J Pediatr; 2006; 48(4):362-4. PubMed ID: 17290574
[TBL] [Abstract][Full Text] [Related]
13. The genomic structure of human BTK, the defective gene in X-linked agammaglobulinemia.
Rohrer J; Parolini O; Belmont JW; Conley ME; Parolino O [corrected to Parolini O]
Immunogenetics; 1994; 40(5):319-24. PubMed ID: 7927535
[TBL] [Abstract][Full Text] [Related]
14. Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation.
Takada H; Kanegane H; Nomura A; Yamamoto K; Ihara K; Takahashi Y; Tsukada S; Miyawaki T; Hara T
Blood; 2004 Jan; 103(1):185-7. PubMed ID: 12958074
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mutations, including a novel regulatory defect in the first intron, in Bruton's tyrosine kinase gene from seven Korean X-linked agammaglobulinemia families.
Jo EK; Kanegane H; Nonoyama S; Tsukada S; Lee JH; Lim K; Shong M; Song CH; Kim HJ; Park JK; Miyawaki T
J Immunol; 2001 Oct; 167(7):4038-45. PubMed ID: 11564824
[TBL] [Abstract][Full Text] [Related]
16. Novel insertions of Bruton tyrosine kinase in patients with X-linked agammaglobulinemia.
Okoh MP; Kainulainen L; Heiskanen K; Isa MN; Varming K; Ruuskanen O; Vihinen M
Hum Mutat; 2002 Dec; 20(6):480-1. PubMed ID: 12442285
[TBL] [Abstract][Full Text] [Related]
17. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A
Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504
[TBL] [Abstract][Full Text] [Related]
18. X-linked agammaglobulinemia. A clinical and molecular analysis.
Ochs HD; Smith CI
Medicine (Baltimore); 1996 Nov; 75(6):287-99. PubMed ID: 8982147
[TBL] [Abstract][Full Text] [Related]
19. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ
J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
